Page last updated: 2024-09-03

gefitinib and Allergy, Drug

gefitinib has been researched along with Allergy, Drug in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grazioso Russi, E; Numico, G; Silvestris, N	1
Figlin, R; Fishbein, MC; Truell, JS	1
Gaya, A; Khorshid, M; Plowman, PN; Walther, JC	1

Reviews

1 review(s) available for gefitinib and Allergy, Drug

Article	Year
Advances in EGFR-directed therapy in head and neck cancer. Frontiers in bioscience (Scholar edition), 2011, 01-01, Volume: 3, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Drug Hypersensitivity; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Gefitinib; Head and Neck Neoplasms; Humans; Lung Diseases, Interstitial; Panitumumab; Protein Kinase Inhibitors; Quinazolines; Radiodermatitis	2011

Article

Year

Advances in EGFR-directed therapy in head and neck cancer.

Frontiers in bioscience (Scholar edition), 2011, 01-01, Volume: 3, Issue:2

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Drug Hypersensitivity; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Gefitinib; Head and Neck Neoplasms; Humans; Lung Diseases, Interstitial; Panitumumab; Protein Kinase Inhibitors; Quinazolines; Radiodermatitis

2011

Other Studies

2 other study(ies) available for gefitinib and Allergy, Drug

Article	Year
Myocarditis temporally related to the use of gefitinib (Iressa). Archives of pathology & laboratory medicine, 2005, Volume: 129, Issue:8 Topics: Acute Disease; Aged; Antineoplastic Agents; Drug Hypersensitivity; Fatal Outcome; Gefitinib; Humans; Male; Myocarditis; Myocytes, Cardiac; Necrosis; Quinazolines	2005
Cross-over response to erlotinib of brain metastatic disease from bronchial adenocarcinoma after gefitinib failure, and an unusual rash. Clinical oncology (Royal College of Radiologists (Great Britain)), 2006, Volume: 18, Issue:8 Topics: Adenocarcinoma; Antineoplastic Agents; Brain Neoplasms; Bronchial Neoplasms; Drug Hypersensitivity; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Middle Aged; Quinazolines; Skin Diseases, Vesiculobullous	2006

Article

Year

Myocarditis temporally related to the use of gefitinib (Iressa).

Archives of pathology & laboratory medicine, 2005, Volume: 129, Issue:8

Topics: Acute Disease; Aged; Antineoplastic Agents; Drug Hypersensitivity; Fatal Outcome; Gefitinib; Humans; Male; Myocarditis; Myocytes, Cardiac; Necrosis; Quinazolines

2005

Cross-over response to erlotinib of brain metastatic disease from bronchial adenocarcinoma after gefitinib failure, and an unusual rash.

Clinical oncology (Royal College of Radiologists (Great Britain)), 2006, Volume: 18, Issue:8

Topics: Adenocarcinoma; Antineoplastic Agents; Brain Neoplasms; Bronchial Neoplasms; Drug Hypersensitivity; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Middle Aged; Quinazolines; Skin Diseases, Vesiculobullous

2006